NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Detechgene

Detechgene

Private
CologneHealthcare & Life Scienceshttps://detechgene.de

Last Round

Seed

Aug 25, 2025

Total Funding Raised

$6.28M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Detechgene is a biotechnology company that develops a mobile rapid molecular diagnostic platform for the detection of viral, bacterial, and fungal pathogens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care testingPOCTmolecular diagnosticsrapid PCRPCRpathogen detectiondiagnostic hardwareisothermal amplificationrazor-and-blademedical devicelab-on-a-chipdecentralized diagnosticsdiagnostic consumablesbiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Detechgene Comparables

Compare Detechgene with similar companies based on industry and business-model similarity.

Detechgene comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anavasi Diagnostics
87%
BIOPIX-T
83%
Danaher Corporation
79%

Detechgene Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 25, 2025
GrantJun 2, 2024

Key People

Founding team and executive leadership

Robin Bayer

CTO And Co-Founder

Founding Team

Reza Esmaillie

CEO And Co-Founder

Founding Team

Detechgene Investors

Notable investors and investment history

Detechgene investors
InvestorRounds
Meerkat HoldingSeed
neoteq venturesSeed
NRW.BankSeed, Pre Seed
Aquarius Invest GmbHSeed
Campus CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    DIAGURIN project launched within the gesünder.in.nrw initiative.

  • Nov 9, 2025

    Received founding category recognition for innovative PCR rapid test.

Detechgene Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Detechgene Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Detechgene's valuation, stock price, and market status.

Firmographic Details

HeadquartersCologne
Employee Range17
Year Founded2022
Last FundingAug 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.